Corvus Pharmaceuticals (CRVS) Restructuring Costs (2024 - 2026)
Corvus Pharmaceuticals' (CRVS) quarterly Restructuring Costs came in at $1.9 million in Q1 2026, up 103.38% year-on-year from $946000.0 in Q1 2025, and up 211.83% quarter-over-quarter from $617000.0 in Q3 2025.
Corvus Pharmaceuticals (CRVS) Restructuring Costs (2024 - 2026) Analysis & Trends
Corvus Pharmaceuticals' Restructuring Costs history runs 3 years deep, the most recent figure standing at $1.9 million for Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Corvus Pharmaceuticals | 1.23 Bn | 1.23 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.92 Mn |
| Sep 30, 2025 | 617,000.00 |
| Jun 30, 2025 | 848,000.00 |
| Mar 31, 2025 | 946,000.00 |
| Sep 30, 2024 | 776,000.00 |
| Jun 30, 2024 | 551,000.00 |
| Mar 31, 2024 | 994,000.00 |